For research use only. Not for therapeutic Use.
HIV-1 Integrase Inhibitor 2(Cat No.:I005681)is a potent compound targeting the HIV-1 integrase enzyme, which is essential for viral replication. By inhibiting the strand transfer step of the integration process, it prevents the incorporation of viral DNA into the host genome, halting the replication cycle. This inhibitor demonstrates high efficacy against resistant strains, making it a valuable tool in antiretroviral therapy development. HIV-1 Integrase Inhibitor 2 is extensively studied in virology for its role in improving therapeutic regimens, enhancing treatment outcomes, and addressing resistance in HIV-1 management.
Catalog Number | I005681 |
CAS Number | 957890-42-5 |
Synonyms | 2-(6-chloro-2-methyl-4-phenylquinolin-3-yl)pentanoic acid |
Molecular Formula | C21H20ClNO2 |
Purity | ≥95% |
Target | Metabolic Enzyme/Protease |
Solubility | 10 mM in DMSO |
Storage | Store at -20°C |
IUPAC Name | 2-(6-chloro-2-methyl-4-phenylquinolin-3-yl)pentanoic acid |
InChI | InChI=1S/C21H20ClNO2/c1-3-7-16(21(24)25)19-13(2)23-18-11-10-15(22)12-17(18)20(19)14-8-5-4-6-9-14/h4-6,8-12,16H,3,7H2,1-2H3,(H,24,25) |
InChIKey | XRPUJSGGRFQZPJ-UHFFFAOYSA-N |
SMILES | CCCC(C1=C(N=C2C=CC(=CC2=C1C3=CC=CC=C3)Cl)C)C(=O)O |